Goodwin Advises Maguar Capital on the Financing of its Partnership With Schlafender Hase
Goodwin advised Maguar Capital (“Maguar”) on the financing of its partnership with Schlafender Hase GmbH (“Schlafender Hase”), a leading provider of content verification software for the pharmaceutical and medical device industries. As part of the transaction, Maguar acquired a majority stake in the company. Wieland Capital and one of Schlafender Hase’s co-founders will remain significantly invested and continue to support the business alongside Maguar.
Maguar Capital is a Munich-based technology investor specializing in B2B software. The firm invests in small and medium-sized software companies in the DACH region as well as selected European markets and supports management teams in achieving sustainable growth. Maguar’s team combines decades of experience as software entrepreneurs, CEOs, and private equity investors and follows a long-term, partnership-oriented investment approach.
Schlafender Hase is the company behind TVT, the content verification software trusted by health authorities and leading companies in industries where errors are not an option. TVT catches every change, discrepancy or deviation — no matter the format, layout, or language, so you can deliver documentation that’s accurate and compliant.
The Goodwin deal team consisted of Winfried Carli, Marius Garnatz Maskus, and Laura Sollacher (all Private Equity/Debt Finance, Munich).